Font Size: a A A

A Twice-condensed Pdna Polyplex System Based On Small Molecular Weight Polyethylenimine For Peripheral Nerve Crush Injury

Posted on:2020-05-21Degree:MasterType:Thesis
Country:ChinaCandidate:X T ZhaoFull Text:PDF
GTID:2504306188455834Subject:Pharmacy
Abstract/Summary:PDF Full Text Request
Peripheral nerve injury is a common clinical disease,leading to patients’ decreased motor and sensory functions.Patients receiving operations or those with minor injuries need to rely on nerve growth factors,several kinds of protein drugs,to promote nerve repair and regeneration.But,vascular endothelial growth factor(VEGF),with great treating effects,has an extremely short half-life in vivo,poor compliance because of frequent injections and high price.Thus,it is urgent to improve its formulation to solve these problems.Fortunately,Gene therapy can deliver vascular endothelial growth factor plasmid DNA(VEGF p DNA)into cells,enable those transfected cells to express VEGF and nourish injured nerves.However,the use of non-viral vectors is generally limited by their potential toxicity problems,relatively poor transfection abilities,serum stability,or complex construction processes of modified polyplexes.Thus,we develop an efficient and stable polyplex system by convenient construction methods.Here,polyethyleneimine(PEI)1.8 k Da and glutaraldehyde(GA)are used to construct a novel twice-condensed p DNA polyplex system using a one-pot construction method,including p H-responsive-C=N-linkages by which different PEI molecules on one single polyplex can link with each other.This system has good particle sizes and zeta potentials.In addition,serum stabilities are achieved without PEGylation or other chemical modifications using lyophobic segments,but via p H-responsive linkages that ensure the escape of nucleic acids.This polyplex system is used to deliver the p DNA of vascular endothelial growth factor(VEGF)whose half-life period in vivo is only around 30 minutes.Compared with polyplexes prepared using PEI 25 k Da,cells and rats treated with twice-condensed VEGF p DNA polyplexes express significantly more VEGF or myelin basic protein(MBP),and this new polyplex system showed fewer adverse effects in vitro and in vivo.In addition,revascularization and neurogenesis are also discovered in the rat sciatic nerve crush injury model.
Keywords/Search Tags:twice-condensed, vascular endothelial growth factor(VEGF) gene therapy, polyethyleneimine (PEI), glutaraldehyde(GA)
PDF Full Text Request
Related items
Vegf Gene Transfection Experimental Study Of Bone And Soft Tissue Injury
The Significance Of Expression Of Vascular Endothelial Cell Growth Factor Families And Their Receptors In Non-small Cell Lung Carcinoma And Being A Target For Gene Therapy
Study On The Gene Expression Of Vascular Endothelial Growth Factor (VEGF) In Human Esophageal Carcinoma And The Inhibitory Effect Of Antisene VEGF RNA On The Growth Of Esophageal Cancer Cell In Vivo & In Vitro
Study On The Gene Expression Of Vascular Endothelial Growth Factor (VEGF) & Its Receptors In Human Hepatocellular Carcinoma And The Inhibitory Effect Of Antisense VEGF RNA On The Growth Of Liver Cancer Cell In Vivo & In Vitro
Experimental Studies: Neuroprotective Effects Of VEGF On Dopaminergic Cells And The Gene Therapy Of VEGF On Parkinson Disease
Research On Expression Of Vascular Endothelial Growth Factor In The Serum And Urine And Antisense VEGF Gene Therapy Of Bladder Cancer
Experimental Study Of Vegf-targeting Antisense Gene Therapy Of Leukemia
Vascular Endothelial Growth Factor (vegf) In Renal Tubular Epithelial - Mesenchymal Transformation Of The Role And Mechanism Of The Interstitial Cells Of Discussion
To Investigate The Efficacy Of Direct Gene Transfer Of Nacked DNA Encoding Vascular Endothelial Growth Factor Into Ischemic Canine Myocardium
10 Transplantation Of Endothelial Progenitor Cells Transferred By Vascular Endothelial Growth Factor And Base Fibroblast Growth Factor Gene For Neovascularization Of Transplanted Tissue